Type 2 diabetes and depression via microvascular dysfunction, neurodegeneration, inflammation, advanced glycation end products (AGEs), and arterial stiffness. [PDF]
Steens ILM +10 more
europepmc +1 more source
Personalized diet study of dietary advanced glycation end products (AGEs) and fatty acid desaturase 2 (FADS2) genotypes in obesity. [PDF]
Mahmoudinezhad M +3 more
europepmc +1 more source
The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus. [PDF]
Rezaei M +6 more
europepmc +1 more source
Dietary Restriction of Advanced Glycation End-Products (AGEs) in Patients with Diabetes: A Systematic Review of Randomized Controlled Trials. [PDF]
Detopoulou P +9 more
europepmc +1 more source
Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
Sho‐ichi Yamagishi, Takanori Matsui
openalex +2 more sources
Recent Advances in the Associations of Advanced Glycation End Products (Ages) and Cancer [PDF]
Congxiao Zhang, Nessar Ahmed, Qiuyu Wang
openaire +2 more sources
Methylglyoxal and Advanced Glycation End Products (AGEs): Targets for the Prevention and Treatment of Diabetes-Associated Bladder Dysfunction? [PDF]
Oliveira AL +3 more
europepmc +1 more source
Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis. [PDF]
Sellegounder D +4 more
europepmc +1 more source

